Latest Articles and Analysis

State legislative attacks on trans care and abortion undermine health equity and HIV prevention.

Youth mental health crisis worsened; CDC data shows rising suicide attempts among girls and LGBTQ youth.

Payers use prior authorization and step therapy to deny care, driving health disparities.

MPV becoming endemic in MSM communities; vaccine distribution disparities impede response.

Q1 2023 Watch: Tennessee rejecting federal HIV funding; updates on ADAPs, Medicaid, veterans care, and harm reduction.

Tennessee rejects $8.3M in federal HIV prevention funding, threatening surveillance and care programs.

Xylazine contamination of drug supply demands harm reduction response including safe consumption sites.

Nursing shortages and hospital consolidation together degrade patient care and access.

Preview of 2023 federal regulatory priorities: Section 1557, IRA implementation, and prior authorization reform.

2023 outlook: CVS PBM discrimination lawsuit, Medicaid enforcement, and state-sponsored discrimination threats.

HIV-MPV co-infection rates between 28-51% indicate need for targeted interventions and provider education.

Place-based sexual health care in community venues advances HIV/HCV prevention and testing outreach.

Nevada expands syringe vending machines with naloxone, fentanyl strips; anonymity critical for uptake.

Employers can advance health equity through inclusive benefits design and quality provider networks.

US Trans Survey provides critical data on transgender healthcare, discrimination, and social determinants.

State-level MPV surveillance: Black Americans overrepresented in Southern states amid reporting gaps.

2022-2023 respiratory season tracking flu, COVID-19, and RSV with severe early indicators.

Q4 2022 Watch: HHS renewed opioid emergency; CANN launched monkeypox project; HEPLISAV-B hepatitis B vaccine covered.

Louisiana and Washington HCV subscription models save millions but fail elimination goals; cost alone isn't the barrier.

Monitoring report documents HCV treatment access challenges across ADAP, Medicaid, and VA systems.